16-23603447-CTTTACCCTAACTTATGAATAG-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_024675.4(PALB2):c.3552_*11delCTATTCATAAGTTAGGGTAAA(p.His1184_Ter1187delins???) variant causes a stop lost, conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
PALB2
NM_024675.4 stop_lost, conservative_inframe_deletion
NM_024675.4 stop_lost, conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.29
Genes affected
PALB2 (HGNC:26144): (partner and localizer of BRCA2) This gene encodes a protein that may function in tumor suppression. This protein binds to and colocalizes with the breast cancer 2 early onset protein (BRCA2) in nuclear foci and likely permits the stable intranuclear localization and accumulation of BRCA2. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Stoplost variant. No alternative stopcodon identified downstream, so we assume a Nonstop Mediated Decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PALB2 | NM_024675.4 | c.3552_*11delCTATTCATAAGTTAGGGTAAA | p.His1184_Ter1187delins??? | stop_lost, conservative_inframe_deletion | 13/13 | ENST00000261584.9 | NP_078951.2 | |
PALB2 | NM_024675.4 | c.3551_*11delCTATTCATAAGTTAGGGTAAA | 3_prime_UTR_variant | 13/13 | ENST00000261584.9 | NP_078951.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PALB2 | ENST00000261584.9 | c.3552_*11delCTATTCATAAGTTAGGGTAAA | p.His1184_Ter1187delins??? | stop_lost, conservative_inframe_deletion | 13/13 | 1 | NM_024675.4 | ENSP00000261584.4 | ||
PALB2 | ENST00000261584 | c.3551_*11delCTATTCATAAGTTAGGGTAAA | 3_prime_UTR_variant | 13/13 | 1 | NM_024675.4 | ENSP00000261584.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2021 | The c.3552_*11del21 variant, located in coding exon 13 of the PALB2 gene, results from a deletion of 21 nucleotides at nucleotide position 3552, causing a translational frameshift with a predicted alternate stop (p.H1184Qfs*2). This alteration occurs at the 3' terminus of thePALB2 gene, is not expected to trigger nonsense-mediated mRNAdecay, and only impacts the last 3 amino acids of the protein. The exact functional effect of this alteration is unknown. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Dec 23, 2019 | This variant deletes 21 nucleotides in exon 13 and 3' untranslated region of the PALB2 gene, causing a deletion of 3 amino acids in the last exon and addition of 1 amino acid before introducing a stop codon. To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at